SYSTEMIC GLUTATHIONE DEFICIENCY IN SYMPTOM-FREE HIV-SEROPOSITIVE INDIVIDUALS

Roland Buhl, Kenneth J. Holroyd, Andrea Mastrangeli, AndréM M. Cantin, H. Ari Jaffe, Faith B. Wells, Cesare Saltini, Ronald Crystal

Research output: Contribution to journalArticle

551 Citations (Scopus)

Abstract

To find out whether systemic glutathione deficiency is associated with human immunodeficiency virus (HIV) infection, thus contributing to the immunodeficiency state, glutathione concentrations in venous plasma and lung epithelial lining fluid (ELF) of symptom-free HIV-seropositive and normal individuals were measured. Total and reduced glutathione concentrations in the plasma of the HIV-infected subjects were about 30% of those in the normal individuals. Concentrations of these substances in the ELF of HIV-infected subjects were about 60% of those in the controls. There was no correlation between ELF and plasma concentrations of total or reduced glutathione. Since glutathione enhances immune function, glutathione deficiency may contribute to the progressive immune dysfunction of HIV infection.

Original languageEnglish
Pages (from-to)1294-1298
Number of pages5
JournalThe Lancet
Volume334
Issue number8675
DOIs
Publication statusPublished - 2 Dec 1989
Externally publishedYes

Fingerprint

Glutathione
HIV
Virus Diseases
Lung

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Buhl, R., Holroyd, K. J., Mastrangeli, A., Cantin, A. M., Jaffe, H. A., Wells, F. B., ... Crystal, R. (1989). SYSTEMIC GLUTATHIONE DEFICIENCY IN SYMPTOM-FREE HIV-SEROPOSITIVE INDIVIDUALS. The Lancet, 334(8675), 1294-1298. https://doi.org/10.1016/S0140-6736(89)91909-0

SYSTEMIC GLUTATHIONE DEFICIENCY IN SYMPTOM-FREE HIV-SEROPOSITIVE INDIVIDUALS. / Buhl, Roland; Holroyd, Kenneth J.; Mastrangeli, Andrea; Cantin, AndréM M.; Jaffe, H. Ari; Wells, Faith B.; Saltini, Cesare; Crystal, Ronald.

In: The Lancet, Vol. 334, No. 8675, 02.12.1989, p. 1294-1298.

Research output: Contribution to journalArticle

Buhl, R, Holroyd, KJ, Mastrangeli, A, Cantin, AM, Jaffe, HA, Wells, FB, Saltini, C & Crystal, R 1989, 'SYSTEMIC GLUTATHIONE DEFICIENCY IN SYMPTOM-FREE HIV-SEROPOSITIVE INDIVIDUALS', The Lancet, vol. 334, no. 8675, pp. 1294-1298. https://doi.org/10.1016/S0140-6736(89)91909-0
Buhl R, Holroyd KJ, Mastrangeli A, Cantin AM, Jaffe HA, Wells FB et al. SYSTEMIC GLUTATHIONE DEFICIENCY IN SYMPTOM-FREE HIV-SEROPOSITIVE INDIVIDUALS. The Lancet. 1989 Dec 2;334(8675):1294-1298. https://doi.org/10.1016/S0140-6736(89)91909-0
Buhl, Roland ; Holroyd, Kenneth J. ; Mastrangeli, Andrea ; Cantin, AndréM M. ; Jaffe, H. Ari ; Wells, Faith B. ; Saltini, Cesare ; Crystal, Ronald. / SYSTEMIC GLUTATHIONE DEFICIENCY IN SYMPTOM-FREE HIV-SEROPOSITIVE INDIVIDUALS. In: The Lancet. 1989 ; Vol. 334, No. 8675. pp. 1294-1298.
@article{b1cd17dcaeec411181249ff1d8ea7240,
title = "SYSTEMIC GLUTATHIONE DEFICIENCY IN SYMPTOM-FREE HIV-SEROPOSITIVE INDIVIDUALS",
abstract = "To find out whether systemic glutathione deficiency is associated with human immunodeficiency virus (HIV) infection, thus contributing to the immunodeficiency state, glutathione concentrations in venous plasma and lung epithelial lining fluid (ELF) of symptom-free HIV-seropositive and normal individuals were measured. Total and reduced glutathione concentrations in the plasma of the HIV-infected subjects were about 30{\%} of those in the normal individuals. Concentrations of these substances in the ELF of HIV-infected subjects were about 60{\%} of those in the controls. There was no correlation between ELF and plasma concentrations of total or reduced glutathione. Since glutathione enhances immune function, glutathione deficiency may contribute to the progressive immune dysfunction of HIV infection.",
author = "Roland Buhl and Holroyd, {Kenneth J.} and Andrea Mastrangeli and Cantin, {Andr{\'e}M M.} and Jaffe, {H. Ari} and Wells, {Faith B.} and Cesare Saltini and Ronald Crystal",
year = "1989",
month = "12",
day = "2",
doi = "10.1016/S0140-6736(89)91909-0",
language = "English",
volume = "334",
pages = "1294--1298",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "8675",

}

TY - JOUR

T1 - SYSTEMIC GLUTATHIONE DEFICIENCY IN SYMPTOM-FREE HIV-SEROPOSITIVE INDIVIDUALS

AU - Buhl, Roland

AU - Holroyd, Kenneth J.

AU - Mastrangeli, Andrea

AU - Cantin, AndréM M.

AU - Jaffe, H. Ari

AU - Wells, Faith B.

AU - Saltini, Cesare

AU - Crystal, Ronald

PY - 1989/12/2

Y1 - 1989/12/2

N2 - To find out whether systemic glutathione deficiency is associated with human immunodeficiency virus (HIV) infection, thus contributing to the immunodeficiency state, glutathione concentrations in venous plasma and lung epithelial lining fluid (ELF) of symptom-free HIV-seropositive and normal individuals were measured. Total and reduced glutathione concentrations in the plasma of the HIV-infected subjects were about 30% of those in the normal individuals. Concentrations of these substances in the ELF of HIV-infected subjects were about 60% of those in the controls. There was no correlation between ELF and plasma concentrations of total or reduced glutathione. Since glutathione enhances immune function, glutathione deficiency may contribute to the progressive immune dysfunction of HIV infection.

AB - To find out whether systemic glutathione deficiency is associated with human immunodeficiency virus (HIV) infection, thus contributing to the immunodeficiency state, glutathione concentrations in venous plasma and lung epithelial lining fluid (ELF) of symptom-free HIV-seropositive and normal individuals were measured. Total and reduced glutathione concentrations in the plasma of the HIV-infected subjects were about 30% of those in the normal individuals. Concentrations of these substances in the ELF of HIV-infected subjects were about 60% of those in the controls. There was no correlation between ELF and plasma concentrations of total or reduced glutathione. Since glutathione enhances immune function, glutathione deficiency may contribute to the progressive immune dysfunction of HIV infection.

UR - http://www.scopus.com/inward/record.url?scp=0024378711&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024378711&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(89)91909-0

DO - 10.1016/S0140-6736(89)91909-0

M3 - Article

VL - 334

SP - 1294

EP - 1298

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 8675

ER -